Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Prelude Therapeutics Inc

3.05
-0.1900-5.86%
Post-market: 3.090.0400+1.31%16:42 EDT
Volume:119.07K
Turnover:366.29K
Market Cap:191.74M
PE:-2.36
High:3.32
Open:3.23
Low:3.01
Close:3.24
52wk High:4.22
52wk Low:0.6101
Shares:62.87M
Float Shares:2.50M
Volume Ratio:0.68
T/O Rate:4.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2929
EPS(LYR):-1.2929
ROE:-99.45%
ROA:-40.74%
PB:2.79
PE(LYR):-2.36

Loading ...

OverviewCompanyNewsFilings

Prelude Therapeutics: to GET $100 Mln IF Incyte Were to Exercise Option to Buy Program

THOMSON REUTERS
·
Nov 04, 2025

Press Release: Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

Dow Jones
·
Nov 03, 2025

Prelude Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Prelude Therapeutics Files Initial Beneficial Ownership Statement for Director Katina Dorton

Reuters
·
Oct 21, 2025

Prelude Therapeutics Appoints Katina Dorton to Board of Directors, Succeeding Mardi Dier as Audit Committee Chair

Reuters
·
Oct 17, 2025

Prelude Therapeutics Announces Appointment of Katina Dorton, J.d., MBA to Its Board of Directors

THOMSON REUTERS
·
Oct 17, 2025

Prelude Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 23, 2025

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Mar 10, 2026 Pre-Market
Financial Report Announcement
Nov 12, 2025 Pre-Market
Financial Report Announcement
Aug 14, 2025 Pre-Market
Financial Report Announcement
May 06, 2025 Post Market
Financial Report Announcement
Mar 10, 2025 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.51
Current
-4.42
Sector Average
29.64%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.51
Maximum
-0.28
+1 STD
2.46
Minimum
-33.39
-1 STD
-11.30
Average
-4.42

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.